These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18196243)

  • 21. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
    Li HM; Zhang TP; Leng RX; Li XP; Li XM; Pan HF
    Arch Med Res; 2015 Oct; 46(7):551-6. PubMed ID: 26452329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
    Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin and ghrelin in Korean systemic lupus erythematosus.
    Kim HA; Choi GS; Jeon JY; Yoon JM; Sung JM; Suh CH
    Lupus; 2010 Feb; 19(2):170-4. PubMed ID: 19965946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-18 gene polymorphisms in systemic lupus erythematosus: relation to disease status.
    Fouad NA; Baraka EA; Hassan WA
    Egypt J Immunol; 2014; 21(1):1-12. PubMed ID: 25204040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary biomarkers of inflammation in systemic lupus erythematosus.
    Stanescu II; Calenic B; Dima A; Gugoasa LA; Balanescu E; Stefan-van Staden RI; Baicus C; Badita DG; Greabu M
    Ann Anat; 2018 Sep; 219():89-93. PubMed ID: 29621567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.
    McMahon M; Skaggs BJ; Sahakian L; Grossman J; FitzGerald J; Ragavendra N; Charles-Schoeman C; Chernishof M; Gorn A; Witztum JL; Wong WK; Weisman M; Wallace DJ; La Cava A; Hahn BH
    Ann Rheum Dis; 2011 Sep; 70(9):1619-24. PubMed ID: 21670088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
    Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
    Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of T cell recombination excision circles levels in peripheral blood mononuclear cells of systemic lupus erythematosus patients].
    Du ZY; Leng XM; Tang FL
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):500-3. PubMed ID: 20979738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M; El-Gammasy T; Shaheen K; Shokr E
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage.
    Gheita TA; Abdel Rehim DM; Kenawy SA; Gheita HA
    Acta Reumatol Port; 2015; 40(2):145-9. PubMed ID: 26219967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum leptin levels in patients with systemic lupus erythematosus.
    Ma L; Li D; Sookha MR; Fang M; Guan Y; Sun X; Guan J
    Pharmazie; 2015 Nov; 70(11):720-3. PubMed ID: 26790188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S; Ciołkiewicz M
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):179-85. PubMed ID: 17557150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.
    Gasparin AA; Souza L; Siebert M; Xavier RM; Chakr RM; Palominos PE; Brenol JC; Monticielo OA
    Lupus; 2016 Mar; 25(3):227-32. PubMed ID: 26223296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus.
    Vadacca M; Zardi EM; Margiotta D; Rigon A; Cacciapaglia F; Arcarese L; Buzzulini F; Amoroso A; Afeltra A
    Intern Emerg Med; 2013 Dec; 8(8):705-12. PubMed ID: 22127554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.